A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2007
12/05/2007	CN101084436A Methods for identifying compounds for regulating muscle mass or function using dopamine receptors
12/05/2007	CN101084237A Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography
12/05/2007	CN101084018A Gpr41 and modulators thereof for the treatment of insulin-related disorders
12/05/2007	CN101082628A Spectrophotometric measurement in color-based biochemical and immunologigal assays
12/05/2007	CN100352927C Model for neurodegenerative disease
12/05/2007	CN100352805C Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them
12/05/2007	CN100352802C Contrast agent preparation
12/04/2007	US7304032 CD-10 activated prodrug compounds
12/04/2007	US7303741 Bifunctional contrast agents that are operable for both magnetic resonance imaging optical imaging
12/04/2007	US7303740 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence
12/04/2007	US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007	CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007	CA2233903C Medical gas mixtures
11/2007
11/29/2007	WO2007137256A2 Carbon nanotube based imaging agents
11/29/2007	WO2007136439A2 Hyperpolarization methods, systems and compositions
11/29/2007	WO2007136413A2 Biocompatible fluorescent metal oxide nanoparticles
11/29/2007	WO2007135367A2 Screen for inflammatory response molulators
11/29/2007	WO2007076295A3 Nanoclusters for delivery of therapeutics
11/29/2007	WO2007066115A3 Novel imaging agents for fibrosis
11/29/2007	WO2007050379A3 Preventing bacterial or viral infectivity and composition containing infection preventing additive
11/29/2007	WO2006116403A3 Intracellular thermal ablation using nano-particle electron spin resonance heating
11/29/2007	WO2005116226A3 Nanoparticles comprising rna ligands
11/29/2007	US20070277252 Transgenic Non-Human Mammal Comprising A Polynucleotide Encoding Human Or Humanized C5ar
11/29/2007	US20070276208 Process for identifying and treating specified cell types
11/29/2007	US20070276103 Fluorinated Surfactants
11/29/2007	US20070275007 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
11/29/2007	US20070274923 Non-invasive real-time in vivo bioluminescence imaging of local Ca2+ dynamics in living organisms
11/29/2007	US20070274921 Diagnostics and therapeutics for ocular disorders
11/29/2007	US20070274920 neurophysiological assay using information obtained from injecting a neural activity blocker, such as tetrodotoxin, into one hippocampus persistently coactivated pyramidal cell in the uninjected hippocampus that initially discharged independently
11/29/2007	US20070274919 Method for measuring in vivo mutation frequency at an endogenous gene locus
11/29/2007	US20070274918 Software system using a three-dimensional model of a crystal LINGO-1 polypeptide to design an agent that binds LINGO-1 and disables the Nogo; receptor complex; LINGO-1 signaling a negative regulator of myelin production; Lingo-1 antagonists; drug design; multiple sclerosis
11/29/2007	US20070274917 Pharmacologic Method Of Lowering Cholesterol Production
11/29/2007	US20070274916 Method for Identifying Compounds that Affect Expression of Tryptophan Hydroxylase Isoform 2
11/29/2007	US20070274915 Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
11/29/2007	US20070274914 Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
11/29/2007	US20070274913 Preventives/Remedies for Stress Urinary Incontinence and Method of Screening the Same
11/29/2007	US20070274909 Radiation Therapy and Medical Imaging Using Uv Emitting Nanoparticles
11/29/2007	US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007	US20070274907 Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
11/29/2007	CA2640671A1 Engineered antibody-stress protein fusions
11/28/2007	EP1859826A1 Contrast agent-removal system and method of activating the contrast agent-removal system
11/28/2007	EP1859799A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
11/28/2007	EP1859041A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
11/28/2007	EP1480691A4 Agglomerated particles for aerosol drug delivery
11/28/2007	EP1284653B1 Infrared thermography and treatment of sexual dysfunctions
11/28/2007	CN200982969Y Dissolution instrument with transdermal test device
11/28/2007	CN101080241A Targeting agents for molecular imaging
11/28/2007	CN101080240A Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
11/28/2007	CN101078716A Biomarker for response monitoring of CDK inhibitors in the clinic
11/28/2007	CN100351990C Retentate chromatography and protein chip arrays applications in biology and medicine
11/27/2007	US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007	US7300660 immunogens/vaccines against mycobactium tuberculosis
11/27/2007	US7300655 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/27/2007	CA2271683C Coated particles, methods of making and using
11/27/2007	CA2225283C Solid oral diagnostic test meal and methods of use thereof
11/22/2007	WO2007134274A2 Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
11/22/2007	WO2007133950A2 Electrically variable transmission with multiple interconnected gearsets
11/22/2007	WO2007133090A1 Contrast agents
11/22/2007	WO2007133088A1 Contrast agents
11/22/2007	WO2007132806A1 Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method
11/22/2007	WO2007131390A1 Ct negative contrast medium of aqueous matrix for digestive tract and the preparation method thereof
11/22/2007	WO2007087256A3 Method of preparing dendritic drugs
11/22/2007	WO2007028599A3 A fluorescent photoprobe for the imaging of endothelin receptors
11/22/2007	WO2007018671A3 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
11/22/2007	WO2006132850A3 Polymeric marker with high radiopacity for use in medical devices
11/22/2007	WO2006128643A3 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine
11/22/2007	WO2006115416A3 Liposomes
11/22/2007	WO2006106383A8 Photosensitizers and mri enhancers
11/22/2007	US20070269384 Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease
11/22/2007	US20070269382 Nanoparticles and Their Use for Multifunctional Bioimaging
11/22/2007	US20070269381 Ultrasound contrast agent dosage formulation
11/22/2007	US20070269379 Penetration Enhancer Combinations for Transdermal Delivery
11/22/2007	US20070269378 Nadks as Modifiers of Branching Morphogenesis and Methods of Use
11/22/2007	US20070269377 Method of Producing Partial Peptide of Enolase Protein from Plasmodium Falciparum
11/22/2007	US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007	US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007	US20070269369 Modified Fc molecules
11/22/2007	US20070269368 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
11/22/2007	DE102006023456A1 Contrast agent for x-ray and computed tomography diagnostics comprises a microencapsulated substance that releases carbon dioxide on contact with body fluids
11/22/2007	CA2652264A1 Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method
11/22/2007	CA2650455A1 Real-time detection of influenza virus
11/21/2007	EP1856521A2 Modulation of th2 lineage commitment by t-bet
11/21/2007	EP1856268A1 Transgenic mice and use thereof as an experimental model
11/21/2007	EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007	CN101076357A Enzyme inhibitor imaging agents
11/21/2007	CN101076356A Electroporation of mycobacterium and overexpression of antigens in mycobacteria
11/21/2007	CN101076343A Use of A2A adenosine receptor agonists
11/20/2007	US7297326 Ocular diagnosis of Alzheimer's disease
11/20/2007	US7297325 Hydrophilic light absorbing compositions for determination of physiological function
11/20/2007	CA2171743C Nucleotide analogs
11/20/2007	CA2139374C Polyaminated ligands and metal complexes thereof
11/15/2007	WO2007131242A2 Streptavidin-biotin-link antibody-hapten system
11/15/2007	WO2007131084A2 Magnetic resonance imaging contrast agents synthesized using ring-opening metathesis polymerization
11/15/2007	WO2007130487A2 Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors
11/15/2007	WO2007129791A1 X-ray contrast agent using gold nanoparticles and process for preparing the same
11/15/2007	WO2007129574A1 Diagnostic for evaluating gastric evacuation function and/or small intestinal absorption function
11/15/2007	WO2007129311A2 Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
11/15/2007	WO2007128567A1 Use of perfluoralkyl-containing metal complexes as contrast agents for diagnosing alzheimer's disease
11/15/2007	WO2007034196A3 Imaging agents comprising silicon
11/15/2007	WO2003106666A3 Protein c variants with altered properties

1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 354